Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02309892
Title A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Helix BioPharma Corporation
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University Hospitals Case Medical Center Cleveland Ohio United States Details
The University of Texas MD Anderson Cancer Center Houston Texas United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field